Name | Title | Contact Details |
---|
AmeriChoice of New York is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Communications is a Deerfield Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Campbell County Hospital District, doing business as Campbell County Memorial Hospital, operates as a community hospital that provides healthcare services serving patients and residents in Gillette. The company offers emergency medical services, behavioral health services, cancer care, outpatient services, emergency care, home medical care, occupational health services, first aid and CPR services, OB GYN services, audiology, internal medicine, infectious disease care, neurology and pain care, geriatric medicine, nephrology, pulmonary and sleep medicine, urology, home care services, laboratory services, nutritional care, radiology, rehabilitation services, hospice care, ICU services, orthopedics and spine care, surgery, maternal child care, powder river surgery, nursing, and health sciences education programs, as well as ear, nose, and throat care. It also provides dialysis, medical and radiation oncology, daycare, and inpatient services; and patient channel services, including heart diseases and strokes care, pain management, diabetes, breastfeeding, general health and wellness, and other services. In addition, the company offers services in the areas of children's healthcare, diet/exercise programs, mental healthcare, senior healthcare, women's health, pregnancy, workplace healthcare, health assessments, and men's healthcare. Campbell County Hospital District was founded in 1981 and is based in Gillette, Wyoming.
Quadramed is an Electronic Document Management solution for your healthcare network that acts as a repository for downloaded and scanned documents.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.